99mTC-BERH2

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name99mTC-BERH2
Drug Alias NameBSM H22xKi4 (Medac)anti-CD30 (Medac)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine
Mechanisms of ActionTumor necrosis factor receptor superfamily member 8 inhibitors
TargetsTumor necrosis factor receptor superfamily member 8
Therapy Area/IndicationsHodgkin Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedac Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedac Gmbh
Active IndicationsN/A
Inactive IndicationsHodgkin Disease

Other Information

ATC CodeN/A
Related LinksN/A